ATE269064T1 - Impfstoffe gegen den hepatitis b und c virus - Google Patents

Impfstoffe gegen den hepatitis b und c virus

Info

Publication number: ATE269064T1
Authority: AT; Austria
Prior art keywords: hepatitis; viral genome; virus; disclosed; incomplete
Prior art date: 1994-10-05

Application number

AT95938824T

Other languages

English (en)

Inventor

Catherine J Pachuk

Jack Wands

Takaji Wakita

Vincent R Zurawski Jr

Leslie R Coney

Katsutoshi Tokushige

Original Assignee

Apollon Inc

Massachusetts Gen Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-05

Filing date

1995-10-05

Publication date

2004-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26981379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE269064(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-10-05 Application filed by Apollon Inc, Massachusetts Gen Hospital filed Critical Apollon Inc

2004-07-15 Application granted granted Critical

2004-07-15 Publication of ATE269064T1 publication Critical patent/ATE269064T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT95938824T 1994-10-05 1995-10-05 Impfstoffe gegen den hepatitis b und c virus ATE269064T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US31824894A	1994-10-05	1994-10-05
US46785995A	1995-06-06	1995-06-06
PCT/US1995/013552 WO1996010997A1 (en)	1994-10-05	1995-10-05	Hepatitis virus vaccines

Publications (1)

Publication Number	Publication Date
ATE269064T1 true ATE269064T1 (de)	2004-07-15

Family

ID=26981379

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95938824T ATE269064T1 (de)	1994-10-05	1995-10-05	Impfstoffe gegen den hepatitis b und c virus

Country Status (9)

Country	Link
EP (1)	EP0789563B8 (de)
JP (1)	JPH11501204A (de)
AT (1)	ATE269064T1 (de)
AU (1)	AU701747B2 (de)
CA (1)	CA2202088A1 (de)
DE (1)	DE69533167D1 (de)
HU (1)	HUT77870A (de)
NZ (1)	NZ296304A (de)
WO (1)	WO1996010997A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1009763A4 (de)	1996-06-11	2002-08-07	Merck & Co Inc	Synthetische hepatitis-c gene
JP2002125688A (ja) *	2000-10-30	2002-05-08	Tosoh Corp	Ｃ型肝炎ウイルスの高感度検出のためのオリゴヌクレオチドおよび検出法
GB0226722D0 (en) *	2002-11-15	2002-12-24	Glaxo Group Ltd	Vaccine
CU23496A1 (es) *	2004-09-03	2010-02-23	Ct Ingenieria Genetica Biotech	Composición vacunal contra el virus de la hepatitis c

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0485209A1 (de) *	1990-11-08	1992-05-13	Immuno Japan Inc.	Mit Non-A Non-B Hepatitis Virus verwandtes Antigen, Aufspürsysteme für Antikörper, Polynukleotide und Polypeptide
JPH0692996A (ja) *	1991-12-28	1994-04-05	Kunitada Shimotoono	Ｃ型肝炎ウィルス粒子を構成する蛋白質およびその発現
AU666176B2 (en) *	1992-01-31	1996-02-01	Abbott Laboratories	Mammalian expression systems for HCV proteins
WO1993015207A2 (en) *	1992-02-04	1993-08-05	Viagene, Inc.	Hepatitis therapeutics
JPH06141870A (ja) *	1992-03-12	1994-05-24	Tokyo Met Gov Rinshiyou Igaku Sogo Kenkyusho	非ａ非ｂ型肝炎ウイルス抗原をコードするｄｎａ断片
JPH06279500A (ja) *	1992-09-30	1994-10-04	Imuno Japan:Kk	ＨＢｃ融合蛋白粒子およびその製造方法

1995
- 1995-10-05 CA CA002202088A patent/CA2202088A1/en not_active Abandoned
- 1995-10-05 WO PCT/US1995/013552 patent/WO1996010997A1/en not_active Application Discontinuation
- 1995-10-05 AT AT95938824T patent/ATE269064T1/de not_active IP Right Cessation
- 1995-10-05 HU HU9801385A patent/HUT77870A/hu unknown
- 1995-10-05 EP EP95938824A patent/EP0789563B8/de not_active Revoked
- 1995-10-05 DE DE69533167T patent/DE69533167D1/de not_active Expired - Lifetime
- 1995-10-05 JP JP8512752A patent/JPH11501204A/ja not_active Ceased
- 1995-10-05 AU AU40061/95A patent/AU701747B2/en not_active Ceased
- 1995-10-05 NZ NZ296304A patent/NZ296304A/xx unknown

Also Published As

Publication number	Publication date
JPH11501204A (ja)	1999-02-02
NZ296304A (en)	1999-06-29
EP0789563A4 (de)	1998-10-07
DE69533167D1 (de)	2004-07-22
AU4006195A (en)	1996-05-02
WO1996010997A1 (en)	1996-04-18
CA2202088A1 (en)	1996-04-18
EP0789563A1 (de)	1997-08-20
EP0789563B8 (de)	2004-11-17
EP0789563B1 (de)	2004-06-16
HUT77870A (hu)	1998-09-28
AU701747B2 (en)	1999-02-04

Similar Documents

Publication	Publication Date	Title
CA2283464A1 (en)	1998-09-11	Functional dna clone for hepatitis c virus (hcv) and uses thereof
ATE335831T1 (de)	2006-09-15	Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis
ATE369384T1 (de)	2007-08-15	Expression und export von interferon-alpha proteinen als fc fusionsproteine
DK1829551T3 (da)	2011-01-24	Modificeret varmchokprotein-antigenpeptid-kompleks
DE69837708D1 (de)	2007-06-14	Von alphavirus abgeleitete vektoren als impfstoffe gegen eine paramyxovirusinfektion
WO2001039797A3 (en)	2002-01-24	Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
ATE309367T1 (de)	2005-11-15	Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
Giantini et al.	1984	Reovirus type 3 genome segment S4: nucleotide sequence of the gene encoding a major virion surface protein
Hilleman	1965	Immunologic, chemotherapeutic and interferon approaches to control of viral disease
ATE269064T1 (de)	2004-07-15	Impfstoffe gegen den hepatitis b und c virus
Palese et al.	1980	Structure, Genetic structure and genetic variation of influenza viruses
DE69626681D1 (de)	2003-04-17	Konditionell-replizierende virale vektoren und ihre verwendung.
WO1996040764A3 (en)	1997-04-10	Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus
CU23245A1 (es)	2007-10-17	CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS
BR9908540A (pt)	2000-11-28	Molécula de ácido nucleico recombinante, célula hospedeira recombinante, composição farmacêutica, e, processo para induzir uma resposta imune contra vìrus de hepatite c em um humano não infectado por vìrus de hepatite c, para imunizar um humano suscetìvel a vìrus de hepatite c, e para tratar um humano que é infectado com vìrus de hepatite c
BR9508645A (pt)	1997-12-23	Vacina da peritonite infecciosa felina
HUP0103871A2 (hu)	2002-01-28	Rekombináns CELO-vírus és CELO vírus DNS
WO1998023752A3 (de)	1998-07-16	Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
TH63069A (th)	2004-07-23	โคลนก่อการติดเชื้อ
RU97107000A (ru)	1999-05-10	Вакцины против вирусов гепатита
Morrison	2023	mRNA Vaccines and their impact on medicine.
PT1254663E (pt)	2005-04-29	Agente antiviral
US20040001805A1 (en)	2004-01-01	Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA
Teichmann et al.	1999	Genome sequences and protein structures
RU93018105A (ru)	1997-02-10	Штамм рекомбинантного вируса осповакцины, вызывающий иммунитет против вируса венесуэльского энцефаломиелита лошадей в организме животных, и способ его получения

Legal Events

Date	Code	Title	Description
2004-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties